Cited by 111Chemical Synthesis and AnalysisProtein Structure and DynamicsNeuropeptides and Animal Physiology

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Cyclic parathyroid hormone-related protein antagonists: lysine 13 to aspartic acid 17 [i to (i + 4)] side chain to side chain lactamization

Chorev, Michael, Roubini, Eliahu, McKee, Roberta L., Gibbons, Susan W., Goldman, Mark E., Caulfield, Michael P., Rosenblatt, Michael·1991·Biochemistry

DOI 10.1021/bi00238a022

Open this paper in CoChat — free account

Abstract

Cyclization of parathyroid hormone related protein (7-34)amide [PTHrP(7-34)NH2] via covalent bond formation between the epsilon-amino of Lys13 and the beta-carboxyl of Asp17 yielded a 20-membered ring lactam. This analogue, [Lys13,Asp17]PTHrP(7-34)NH2, was 5-10-fold more potent than the linear parent peptide (Kb = 15 and 18 nM in PTH receptor binding assays, and Ki = 130 and 17 nM in PTH-stimulated adenylate cyclase assays in bovine renal cortical membrane and in human bone derived B10 cells, respectively). In contrast, a linear analogue in which charges in positions 13 and 17 were eliminated and other stereoisomers of the above-mentioned lactam in which either Lys13 and/or Asp17 were replaced by the corresponding D-amino acids were much less potent with regard to antagonist bioactivity than the parent peptide. The rationale for the design of the lactam as well as the conformational implications for the PTHrP sequence in light of reported models suggested for the 1-34 peptide are described. The potential use of conformationally constrained analogues for elucidating the "bioactive conformation" of antagonists and for the design of substantially simplified molecular structures for antagonists is discussed.

Integrity signals

Registry

Crossref · 10.1021/bi00238a022

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
A Parathyroid Hormone-Related Protein Implicated in Malignant Hypercalcemia: Cloning and Expression
Suva, L. J., Winslow, G. A., Wettenhall, R. E. H., Hammonds, R. G., Moseley, J. M., Diefenbach-Jagger, H., Rodda, C. P., Kemp, B. E., Rodriguez, H., Chen, E. Y., et al. (1987) · Science · doi:10.1126/science.3616618 · Cited by 1,292
Conformation and Biological Activity of Cyclic Peptides
Kessler, H. (1982) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198205121 · Cited by 868
Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors.
Mosberg, H. I., Hurst, R., Hruby, V. J., Gee, K., Yamamura, H. I., Galligan, J. J., & Burks, T. F. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.19.5871 · Cited by 740
Parathyroid hormone-related protein purified from a human lung cancer cell line.
Moseley, J. M., Kubota, M., Diefenbach-Jagger, H., Wettenhall, R. E. H., Kemp, B. E., Suva, L. J., Rodda, C. P., Ebeling, P. R., Hudson, P. J., & Zajac, J. D. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.14.5048 · Cited by 734
Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone.
Strewler, G. J., Stern, P. H., Jacobs, J., Eveloff, J., Klein, R. F., Leung, S. C., Rosenblatt, M., & Nissenson, R. A. (1987) · Journal of Clinical Investigation · doi:10.1172/jci113275 · Cited by 533
Self-citation
The benzodiazepine story
Sternbach, L. H. (1979) · Journal of Medicinal Chemistry · doi:10.1021/jm00187a001 · Cited by 447
Identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy.
Mangin, M., Webb, A. C., Dreyer, B. E., Posillico, J. T., Ikeda, K., Weir, E. C., Stewart, A. F., Bander, N. H., Milstone, L. M., & Barton, D. E. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.2.597 · Cited by 428
Conformational restrictions of biologically active peptides via amino acid side chain groups
Hruby, V. J. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90578-1 · Cited by 401
Parathyroid Hormone-Related Protein of Malignancy: Active Synthetic Fragments
Kemp, B. E., Moseley, J. M., Rodda, C. P., Ebeling, P. R., Wettenhall, R. E. H., Stapleton, D., Diefenbach-Jagger, H., Ure, F., Michelangeli, V. P., Simmons, H. A., et al. (1987) · Science · doi:10.1126/science.3685995 · Cited by 373
Similarity of Synthetic Peptide from Human Tumor to Parathyroid Hormone in Vivo and in Vitro
Horiuchi, N., Caulfield, M. P., Fisher, J. E., Goldman, M. E., McKee, R. L., Reagan, J. E., Levy, J. J., Nutt, R. F., Rodan, S. B., Schofield, T. L., et al. (1987) · Science · doi:10.1126/science.3685994 · Cited by 353
Self-citation
The parathyroid hormone-like peptide associated with humoral hypercalcemia of malignancy and parathyroid hormone bind to the same receptor on the plasma membrane of ROS 17/2.8 cells.
Jüppner, H., Abou‐Samra, A., Uneno, S., Gu, W. X., Potts, J. T. J., & Segre, G. V. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68339-5 · Cited by 245
N-Terminal amino acid sequence of two novel tumor-derived adenylate cyclase-stimulating proteins: Identification of parathyroid hormone-like and parathyroid hormone-unlike domains
Stewart, A. F., WU, T. L., Goumas, D., Burtis, W. J., & Broadus, A. E. (1987) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(87)90581-x · Cited by 234
Synthesis, biological activity and conformational analysis of cyclic GRF analogs
Felix, A. M., Heimer, E. P., Wang, C., LAMBROS, T. J., Fournier, A., Mowles, T. F., MAINES, S., Campbell, R. M., Wegrzynski, B. B., Toome, V., et al. (1988) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1988.tb01375.x · Cited by 221
Factors associated with humoral hypercalcemia of malignancy stimulate adenylate cyclase in osteoblastic cells.
Rodan, S. B., Insogna, K. L., Vignery, A., Stewart, A. F., Broadus, A. E., D'Souza, S. M., Bertolini, D. R., Mundy, G. R., & Rodan, G. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111108 · Cited by 221
Synthesis and pharmacological characterization in vitro of cyclic enkephalin analogs: effect of conformational constraints on opiate receptor selectivity
DiMaio, J., Nguyen, T. M. ‐., Lemieux, C., & Schiller, P. W. (1982) · Journal of Medicinal Chemistry · doi:10.1021/jm00354a008 · Cited by 199
Human renal carcinoma expresses two messages encoding a parathyroid hormone-like peptide: evidence for the alternative splicing of a single-copy gene.
Thiede, M. A., Strewler, G. J., Nissenson, R. A., Rosenblatt, M., & Rodan, G. A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.13.4605 · Cited by 196
Self-citation
Why cyclic peptides? Complementary approaches to conformations
Deber, C. M., Madison, V., & BLOUT, E. R. (1976) · Accounts of Chemical Research · doi:10.1021/ar50099a005 · Cited by 196
Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy.
Stewart, A. F., Insogna, K. L., Goltzman, D., & Broadus, A. E. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.5.1454 · Cited by 179
Human renal carcinoma cells produce hypercalcemia in the nude mouse and a novel protein recognized by parathyroid hormone receptors.
Strewler, G. J., Williams, R. D., & Nissenson, R. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110825 · Cited by 173
A super active cyclic hexapeptide analog of somatostatin
Veber, D. F., Saperstein, R., Nutt, R. F., Freidinger, R. M., Brady, S. F., Curley, P., Perlow, D. S., Paleveda, W. J., COLTON, C. D., Zacchei, A. G., et al. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90009-2 · Cited by 166
Synthetic peptides comprising the amino-terminal sequence of a parathyroid hormone-like protein from human malignancies. Binding to parathyroid hormone receptors and activation of adenylate cyclase in bone cells and kidney.
Nissenson, R. A., Diep, D., & Strewler, G. J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37641-5 · Cited by 155
Conformationally restricted bicyclic analogs of somatostatin.
Veber, D. F., Holly, F. W., Paleveda, W. J., NUTT, R. F., Bergstrand, S. J., Torchiana, M. L., Glitzer, M. S., Saperstein, R., & Hirschmann, R. F. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.6.2636 · Cited by 144
Applications of BOP reagent in solid phase synthesis
Felix, A. M., Wang, C., Heimer, E. P., & Fournier, A. (1988) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1988.tb00028.x · Cited by 142
A cyclic enkephalin analog with high in vitro opiate activity.
DiMaio, J., & Schiller, P. W. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7162 · Cited by 125
The design of metabolically-stable peptide analogs
Veber, D. F., & Freidinger, R. M. (1985) · Trends in Neurosciences · doi:10.1016/0166-2236(85)90140-7 · Cited by 99
Identification of a Receptor-Binding Region in Parathyroid Hormone*
Rosenblatt, M., Segre, G. V., Tyler, G. A., Shepard, G. L., Nussbaum, S. R., & Potts, J. T. J. (1980) · Endocrinology · doi:10.1210/endo-107-2-545 · Cited by 89
Self-citation
Modifications of position 12 in a parathyroid hormone and parathyroid hormone-related protein: toward the design of highly potent antagonists
Chorev, M., Goldman, M. E., McKee, R. L., Roubini, E., Levy, J. J., GAY, C. T., Reagan, J. E., Fisher, J. E., & Caporale, L. H. (1990) · Biochemistry · doi:10.1021/bi00458a032 · Cited by 75
Self-citation
Influence of the Amino-Terminus onin Vitroandin VivoBiological Activity of Synthetic Parathyroid Hormone-Like Peptides of Malignancy*
Rabbani, S. A., MITCHELL, J., ROY, D. R., Hendy, G. N., & Goltzman, D. (1988) · Endocrinology · doi:10.1210/endo-123-6-2709 · Cited by 75
THE 7–34-FRAGMENT OF HUMAN HYPERCALCEMIA FACTOR IS A PARTIAL AGONIST/ANTAGONIST FOR PARATHYROID HORMONESTIMULATED CAMP PRODUCTION
McKee, R. L., Goldman, M. E., Caulfield, M. P., DeHAVEN, P. A., Levy, J. J., Nutt, R. F., & Rosenblatt, M. (1988) · Endocrinology · doi:10.1210/endo-122-6-3008 · Cited by 70
Self-citation
Conformational Prerequisites for the in vitro Inhibition of Cholate Uptake in Hepatocytes by Cyclic Analogues of Antamanide and Somatostatin
Kessler, H., KLEIN, M., Müller, A., Wagner, K., Bats, J. W., Ziegler, K., & Frimmer, M. (1986) · Angewandte Chemie International Edition in English · doi:10.1002/anie.198609971 · Cited by 66
NMR study of a 34‐residue N‐terminal fragment of the parathyroid‐hormone‐related protein secreted during humoral hypercalcemia of malignancy
Barden, J. A., & Kemp, B. E. (1989) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1989.tb15030.x · Cited by 66
Interaction of human parathyroid hormone-related peptide with parathyroid hormone receptors in clonal rat osteosarcoma cells.
Shigeno, C., Yamamoto, I., Kitamura, N., Noda, T., Lee, K., Sone, T., SHIOMI, K., Ohtaka, A., Fujii, N., & YAJIMA, H. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81369-8 · Cited by 64
Evaluation of Novel Parathyroid Hormone Analogs Using a Bovine Renal Membrane Receptor Binding Assay
Goldman, M. E., Chorev, M., Reagan, J. E., Nutt, R. F., Levy, J. J., & Rosenblatt, M. (1988) · Endocrinology · doi:10.1210/endo-123-3-1468 · Cited by 62
Self-citation
REMOVAL OP PARTIAL AOONISM PROM PARATHYROID HORMONE (PTH)-RELATED PROTEIN-(7-34)NH2BY SUBSTITUTION OP PTH AMINO ACIDS AT POSITIONS 10 AND 11
Nutt, R. F., Caulfield, M. P., Levy, J. J., Gibbons, S. W., Rosenblatt, M., & McKee, R. L. (1990) · Endocrinology · doi:10.1210/endo-127-1-491 · Cited by 62
Self-citation
[1-Penicillamine,2-leucine]oxytocin. Synthesis and pharmacological and conformational studies of a potent peptide hormone inhibitor
Hruby, V. J., Deb, K. K., Yamamoto, D. M., Hadley, M. E., & Chan, W. Y. (1979) · Journal of Medicinal Chemistry · doi:10.1021/jm00187a002 · Cited by 36
Parathyroid hormone inhibitors. Determination of minimum sequence requirements.
Mahaffey, J. E., Rosenblatt, M., Shepard, G. L., & Potts, J. T. J. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50395-1 · Cited by 33
Self-citation
Design of peptide hormone and neurotransmitter analogues
Hruby, V. J. (1985) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(85)90119-1 · Cited by 31
Treatment of Bone-Derived ROS 17/2.8 Cells with Dexamethasone and Pertussis Toxin Enables Detection of Partial Agonist Activity for Parathyroid Hormone Antagonists
McKee, R. L., Caulfield, M. P., & Rosenblatt, M. (1990) · Endocrinology · doi:10.1210/endo-127-1-76 · Cited by 29
Self-citation
Two‐dimensional 1H‐NMR study of the 1–34 fragment of human parathyroid hormone
Lee, S. C., & Russell, A. F. (1989) · Biopolymers · doi:10.1002/bip.360280606 · Cited by 25
Conformational requirements for norepinephrine uptake inhibition by phenethylamines in brain synaptosomes. Effects of .alpha.-alkyl substitution
Jong, A. P. D., Fesik, S. W., & Makriyannis, A. (1982) · Journal of Medicinal Chemistry · doi:10.1021/jm00354a009 · Cited by 21
Peptide conformation
Kessler, H., KLEIN, M., & Wagner, K. (1988) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1988.tb00907.x · Cited by 16
Pharmacological, conformational and dynamic properties of cycloleucine‐2 analogues of oxytocin and [1‐penicillamine]oxytocin
Hruby, V. J., Rockway, T. W., Viswanatha, V., & Chan, W. Y. (1983) · International journal of peptide & protein research · doi:10.1111/j.1399-3011.1983.tb03074.x · Cited by 15
PREPARATION OF N-1-BUTYLOXYCARBONYL-Oω-9-FLUORENYLMETHYL ESTERS OF ASPARTIC AND GLUTAMIC ACIDS
Bolin, D. R., Wang, C.-T., & Felix, A. M. (1989) · Organic Preparations and Procedures International · doi:10.1080/00304948909356348 · Cited by 13

Sorted by citations

Inhibition of α-helix-mediated protein–protein interactions using designed molecules
Azzarito, V., Long, K., Murphy, N. S., & Wilson, A. J. (2013) · Nature Chemistry · doi:10.1038/nchem.1568 · Cited by 727
Structure‐Based Design of Inhibitors of Protein–Protein Interactions: Mimicking Peptide Binding Epitopes
Pelay‐Gimeno, M., Glas, A., Koch, O., & Grossmann, T. N. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201412070 · Cited by 740
Design of Folded Peptides
Venkatraman, J., Shankaramma, S. C., & Balaram, P. (2001) · Chemical Reviews · doi:10.1021/cr000053z · Cited by 699
Modulators of Protein–Protein Interactions
Milroy, L.-G., Grossmann, T. N., Hennig, S., Brunsveld, L., & Ottmann, C. (2014) · Chemical Reviews · doi:10.1021/cr400698c · Cited by 497
Constraining Cyclic Peptides To Mimic Protein Structure Motifs
Hill, T. A., Shepherd, N. E., Diness, F., & Fairlie, D. P. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201401058 · Cited by 431

See all 111

Authors: Chorev, M., Roubini, E., McKee, R. L., Gibbons, S. W., Goldman, M. E., Caulfield, M. P., & Rosenblatt, M.
Affiliations: Hebrew University of Jerusalem (IL)
ORCID: Chorev, Michael
Venue: Biochemistry
Publisher: American Chemical Society (ACS)
Published: 1991-06-18
Volume: 30
Issue: 24
Pages: 5968-5974
ISSN: 0006-2960 (ISSN-L)
1520-4995
DOI: 10.1021/bi00238a022
OpenAlex: W2075824919
Cited by: 107
References: 44
Citations by year: 2026: 1 · 2025: 1 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 7 · 2019: 3 · 2018: 5 · 2017: 4 · 2015: 6 · 2014: 8 · 2013: 3 · 2012: 2
FWCI: 0.93
Type: journal article
Language: en
Open access: closed
Locations: Biochemistry (publishedVersion)
PubMed (publishedVersion)
Topics: Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
Keywords: parathyroid hormone-related protein, cyclic peptide analogues, lactamization, peptide cyclization, conformationally constrained analogues, bioactive conformation, adenylate cyclase activation
MeSH terms: Adenylyl Cyclases, Amino Acid Sequence, Animals, Cattle, Cell Line, Cell Membrane, Humans, Indicators and Reagents, Kidney Cortex, Lactams, Molecular Sequence Data, Parathyroid Hormone, Peptides, Cyclic, Protein Conformation, Proteins, Receptors, Cell Surface, Osteosarcoma, Structure-Activity Relationship, Receptors, Parathyroid Hormone, Parathyroid Hormone-Related Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cyclic parathyroid hormone-related protein antagonists: lysine 13 to aspartic acid 17 [i to (i + 4)] side chain to side chain lactamization

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks